Skip to main content

As part of an academic medical center, the Liver Center is responsible not just for treating patients but also for finding ways to improve the way doctors diagnose and treat all forms of liver disease. Physicians within the Liver Center contribute to research and participate in clinical trials to ensure that their patients receive access to the absolute latest developments that could help treat their disease. 

PATIENTS: Sign up for the Registry for Liver Disease

To learn more about the University of Maryland Registry for Liver Disease and clinical trial options, contact the Clinical Coordinator at or 410-706-8830.

Surgical treatment and medical management of liver disease have improved significantly in recent history; however, new therapies are constantly in development and could benefit the patient or a future patient during the advanced experimental stages.

The Liver Center at the University of Maryland is now enlisting patients with liver disease or those who have had a liver transplant who are interested in learning more about clinical trials for the treatment of:

  • Hepatitis B
  • Hepatitis C
  • Non-alcoholic fatty liver disease (NASH)
  • Hemochromatosis
  • Wilson Disease
  • Alpha-1-antitrypsin
  • Alcohol-related liver disease
  • Drug-induced liver disease
  • Autoimmune hepatitis
  • Primary biliary cirrhosis (PBC)
  • Primary sclerosing cholangitis (PSC)
  • Hepatocellular carcinoma
  • Cholangiocarcinoma
  • Other forms of liver and hepatobiliary disease

By voluntarily joining the Registry for Liver Disease, patients have the opportunity to receive notifications from the University of Maryland Liver Center about clinical trials for their specific condition.

Eligibility criteria for joining the Registry:

  • Must be 18 years or older AND
  • Diagnosed with liver disease OR
  • Have had a liver transplant